Rifampin Drug-Drug Interaction Study With Lurasidone HCl

Clinical trial NCT01082276 · COMPLETED

Trial details

NCT number: NCT01082276
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Male, Healthy Normal Subjects

Start date: 2008-08-01
Primary completion: 2008-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.